Your widget preview
RSS feeds
Be the first to announce the news!!
|
FDA approves cancer treatment for dogs WASHINGTON (AP) -- The Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs.... The Arizona RepublicFDA aims to make its decisions more transparent WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had formed a task force to look for ways to make its decisions regarding medicine and public health matters more transparent. ReutersDiet and Breast Cancer Risk Having a healthy weight depends on smart choices for food, drink, and exercise. Keeping off excess pounds means balancing all these factors, to lower your overall risk for cancers, especially breast cancer. There's no particular food that guarantees you won't develop breast cancer, or have a recurrence of it. But a healthy diet has many benefits. Learn about diet and cancer risk. AboutSenate weighs new FDA tobacco controls WASHINGTON (Reuters) - U.S. senators began debating on Tuesday whether to grant the Food and Drug Administration new power to regulate tobacco products, a proposal that has divided the cigarette industry. ReutersMice Sensing Leptin Stave Off Diabetes [The following is an exact transcript of this podcast.]Leptin is a hormone made by fat cells that tells you when you’re full. If you didn’t have leptin--and some people don’t--you’d eat too way too much, get real fat and almost certainly develop diabetes. Leptin acts like a natural appetite suppressant. Kids born without the hormone can top 100 pounds before they hit kindergarten. And mice without leptin are sluggish balls of blubber. But how does leptin work its dietary wonders? [More] Presented By: You Need the Speed of Norton 2009 Introducing the revolutionary Norton Internet Security 2009. With a one-click, one-minute install, under 7MB of memory usage and fewer, shorter scans, it?s the fastest security suite anywhere. Get your FREE trial today!Click to Learn More www.norton.com/speed Ads by Pheedo New York TimesClinical Data to send depression drug to FDA Clinical Data Inc. has announced it will file a New Drug Application with the Food and Drug Administration for a possible treatment for depression. The news follows positive results from the second of... bignewsnetwork.comIntroducing The Pioneering XTRAC VelocityT Excimer Laser: Delivers Psoriasis And Vitiligo Treatments Three Times Faster PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, announced the availability of its groundbreaking XTRAC VelocityT Excimer Laser, a device expected to redefine laser treatment options for patients suffering from psoriasis and vitiligo. Medical News TodayARCA Biopharma Receives Complete Response Letter From FDA On The GencaroTM NDA ARCA biopharma, Inc. (Nasdaq:ABIO) announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA, or the Agency) for its New Drug Application (NDA) seeking approval for GencaroTM (bucindolol hydrochloride) for the treatment of patients with chronic heart failure. Medical News TodaySepracor`s STEDESAT (Eslicarbazepine Acetate) New Drug Application Formally Accepted For Review By The FDA Sepracor Inc. (Nasdaq: SEPR) today announced that it has been notified by the U.S. Food and Drug Administration (FDA) that the New Drug Application (NDA) for STEDESAT (eslicarbazepine acetate) has been accepted for filing and is now under formal review. Medical News TodayBausch & Lomb Receives FDA Approval Of BesivanceT, New Topical Ophthalmic Anti-Infective For The Treatment Of Bacterial Conjunctivitis (``Pink Ey Bausch & Lomb, a world leader in eye health, today announced that the U.S. Food and Drug Administration (FDA) approved BesivanceT (besifloxacin ophthalmic suspension) 0.6% for the treatment of bacterial conjunctivitis, commonly referred to as 'pink eye.' BesivanceT is a new topical ophthalmic anti-infective, administered via sterile ophthalmic drops, that treats a wide range of eye pathogens including those that most commonly cause bacterial conjunctivitis. Medical News Today1 2 3 |
Updating news archive  |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Popular search keywords in health:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available news archives.
How does Feedzilla work?
Feedzilla is a news aggregator which categorizes news stories by topic. It is a platform where webmasters and bloggers can find an unmatched selection of easy to use, automatically updating and professional news widgets for their sites. Feedzilla supports the building of widgets in various formats, as well as allowing the addition of news widgets to different blogging platforms and social networks.
Feedzilla manually aggregates news summaries found in RSS feeds, and redistributes them in either RSS format or as a news widget. Content is collected 24 hours a day, 7 days a week from an ever-growing list of providers.
Hot keywords
accused plot • accused seeking • acting attorney • administration plans • alive scottish • already fretting • american shopping • attack mall • attack malls • big pay • black barbies • board building • building downtown • bulatci attempted • charged providing • chinas gdp • companies already • companies received • compensation board • compensation highest • de janeiro • death rcmp • downtown edmonton • draft deal • edmonton surrendered • ends surrender • england man • failed terrorist • firms obama • found body • fretting holiday • friends tried • gunman held • halloween offers • held hostages • heroin trade • hn vaccine • holiday shopping • hostages edmonton • hostages workers • iran nuclear • kill kidnap • kill politicians • kill prominent • lockerbie bomber • maim injure • mall attack • malls authorities • man charged • manslaughter shooting • mass man • massachusetts man • material support • missile defense • mountie murder • muslim school • north korea • nuclear watchdog • nuclear weapons • obama administration • offers hope • officer hay • olympics rio • order companies • overseas kill • paid executives • pay cuts • percent quarter • planning trips • plea rejected • plead guilty • plot attack • police looking • politicians randomly • president joe • purple lady • recession companies • rife favoritism • river nwt • season halloween • seeking training • shoot people • shopping mall • shopping season • surrender gunman • swine flu • tarek mehanna • terror plot • terror suspect • then plotted • too westernized • training camps • training taliban • trial emrah • workers compensation •
News poll
Press release
9th of September 2009 - Interview of Feedzilla's founder at the IFA in Berlin. [More]
Testimonials
Your content made me earn some additional revenue! Thank you so much!
Khalid Mustafa
© 2009 Butterfly Effect SA